title: Liver Function Profile Anomalies in HIV Seropositive Tuberculosis.
abstract: BACKGROUND
  The Human Immunodeficiency Virus (HIV) and the Tuberculosis (TB) co infection are contributory to each other in causing a progressive decline in the cell mediated immunity and a damage to the hepatobiliary system. The aim of our study was to estimate the extent of liver damage which was caused by these infections before the start of the therapy with hepatotoxic drugs like Antiretroviral Therapy (ART) and Antitubercular Drugs (ATD).
  
  
  METHODS
  One hundred and ninty three confirmed HIV positive cases were enrolled in this study. The cases were divided into 2 groups; Group 1-100 subjects with TB and Group 2-93 subjects without TB.80 age and sex matched controls were also included (Group 0). Some parameters of the serum Liver Function Test (LFT) were estimated biochemically by using an auto analyzer (ERBA XL600,Transasia).
  
  
  RESULTS
  The serum total bilirubin, Alanine Transaminase (ALT), Aspartate Transaminase (AST) and the Alkaline Phosphatase (ALK-P) levels were significantly higher in the cases as compared to those in the controls, more so in the cases with the associated TB co infection, except the AST levels. The Group 1subjects had lower serum total protein and albumin levels and altered albumin/globulin ratios as compared to the controls. A statistically significant difference was absent in the serum total protein levels between the Group 2 cases and the Group 0 controls. No significant differences were observed when the values for serum total protein, albumin and globulin and the albumin: globulin ratios among the two case groups (1 and 2) were compared.
  
  
  CONCLUSIONS
  The results have shown the importance of estimating some LFT parameters, prior to the start of ATD and ART in these cases. Hence, a mandatory performance of LFT is recommended, as it is simple and cost effective.
authors.affiliation: Professor & Head, Department of Pulmonary Medicine, Calcutta National Medical College , Kolkata, West Bengal,India .
authors.forename: Subir Kumar
authors.initials: SK
authors.lastname: Dey
authors.forename: Indranath
authors.initials: I
authors.lastname: Ghosh
authors.forename: Debojyoti
authors.initials: D
authors.lastname: Bhattacharjee
authors.forename: Praveen
authors.initials: P
authors.lastname: A
authors.forename: Sumanta
authors.initials: S
authors.lastname: Jha
authors.forename: Anindya
authors.initials: A
authors.lastname: Dasgupta
authors.forename: Sukanta Kumar
authors.initials: SK
authors.lastname: Dey
keywords: Human Immunodeficiency Virus (HIV); Liver Function Test (LFT); Tuberculosis (TB)
references.citation: Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):555-61
references.pmid: 8268773
references.citation: J Clin Invest. 1995 May;95(5):2324-31
references.pmid: 7738195
references.citation: J Infect Dis. 2003 Nov 15;188(10):1412-20
references.pmid: 14624365
references.citation: Am J Med. 1990 Feb;88(2):123-30
references.pmid: 2405658
references.citation: Gastroenterol Clin Biol. 1988 May;12(5):465-72
references.pmid: 2900180
references.citation: Ann Intern Med. 1987 Apr;106(4):546-9
references.pmid: 3548523
references.citation: Am J Med. 1989 May;86(5):539-46
references.pmid: 2712061
references.citation: Gut. 1993 Jan;34(1):116-21
references.pmid: 8381757
references.citation: Ann Med Interne (Paris). 1990;141(5):459-63
references.pmid: 2175155
references.citation: JAMA. 1995 Jan 18;273(3):220-6
references.pmid: 7807661
references.citation: J Infect Dis. 1991 Apr;163(4):866-9
references.pmid: 2010640
references.citation: Ann Intern Med. 1985 Nov;103(5):704-9
references.pmid: 2996403
references.citation: Am J Gastroenterol. 1987 Mar;82(3):231-6
references.pmid: 3826029
references.citation: N Engl J Med. 1994 Jun 16;330(24):1703-9
references.pmid: 7910661
references.citation: Bull World Health Organ. 1992;70(4):515-26
references.pmid: 1394786
references.citation: Ann Intern Med. 1986 Aug;105(2):207-10
references.pmid: 3014940
references.citation: Res Virol. 1993 Jan-Feb;144(1):7-12
references.pmid: 8446781
references.citation: Afr J Med Med Sci. 1994 Dec;23(4):385-9
references.pmid: 7653407
references.citation: Lancet. 1993 Jul 31;342(8866):268-72
references.pmid: 8101302
references.citation: J Acquir Immune Defic Syndr (1988). 1994 Jul;7(7):727-33
references.pmid: 8207650
references.citation: Int J Tuberc Lung Dis. 2007 Jan;11(1):78-84
references.pmid: 17217134
references.citation: Abdom Imaging. 1994 Sep-Oct;19(5):423-4
references.pmid: 7950817
references.citation: J Infect Dis. 2002 Jul 1;186(1):23-31
references.pmid: 12089658
references.citation: JAMA. 1999 Aug 18;282(7):677-86
references.pmid: 10517722
references.citation: N Engl J Med. 1994 Jun 16;330(24):1710-6
references.pmid: 7993412
references.citation: Hum Pathol. 1990 Apr;21(4):404-8
references.pmid: 2108080